Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay Probe, RNA, 96
The Agilent SureSelect Tumor Map RNA Probe Kit (96 reactions) is designed for use in targeted RNA sequencing applications, enabling comprehensive profiling of gene expression in tumor samples. This kit provides high-quality, biotinylated RNA probes for hybrid capture, facilitating the enrichment of specific RNA targets from complex biological samples. The kit is optimized for use with the SureSelect workflow, ensuring compatibility with Agilent's NGS library preparation and sequencing platforms. It supports robust and reproducible results, making it suitable for cancer research and biomarker discovery.